Israeli and American researchers uncovered the role of a specific enzyme in managing blood sugar levels in a study that opens up new therapeutic possibilities for people with type 2 diabetes. Type 2 ...
On day 1, GLP-1 was infused to stimulate endogenous insulin release and suppress endogenous glucagon. On days 2–5, pancreatic endocrine clamps were performed using somatostatin infusions of ...